vs
Side-by-side financial comparison of MURPHY OIL CORP (MUR) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.
PERRIGO Co plc is the larger business by last-quarter revenue ($1.1B vs $613.1M, roughly 1.8× MURPHY OIL CORP). MURPHY OIL CORP runs the higher net margin — 1.9% vs -127.8%, a 129.7% gap on every dollar of revenue. On growth, PERRIGO Co plc posted the faster year-over-year revenue change (-2.5% vs -8.4%). Over the past eight quarters, PERRIGO Co plc's revenue compounded faster (1.3% CAGR vs -12.2%).
Murphy Oil Corporation is an American energy company engaged in hydrocarbon exploration headquartered in Houston, Texas.
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
MUR vs PRGO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $613.1M | $1.1B |
| Net Profit | $11.9M | $-1.4B |
| Gross Margin | — | 32.6% |
| Operating Margin | 9.7% | -116.0% |
| Net Margin | 1.9% | -127.8% |
| Revenue YoY | -8.4% | -2.5% |
| Net Profit YoY | -76.3% | -3093.9% |
| EPS (diluted) | $0.08 | $-10.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $613.1M | $1.1B | ||
| Q3 25 | $721.0M | $1.0B | ||
| Q2 25 | $683.0M | $1.1B | ||
| Q1 25 | $672.7M | $1.0B | ||
| Q4 24 | $669.6M | $1.1B | ||
| Q3 24 | $753.2M | $1.1B | ||
| Q2 24 | $801.0M | $1.1B | ||
| Q1 24 | $794.8M | $1.1B |
| Q4 25 | $11.9M | $-1.4B | ||
| Q3 25 | $-3.0M | $7.5M | ||
| Q2 25 | $22.3M | $-8.4M | ||
| Q1 25 | $73.0M | $-6.4M | ||
| Q4 24 | $50.4M | $-44.4M | ||
| Q3 24 | $139.1M | $-21.0M | ||
| Q2 24 | $127.7M | $-108.4M | ||
| Q1 24 | $90.0M | $2.0M |
| Q4 25 | — | 32.6% | ||
| Q3 25 | — | 36.1% | ||
| Q2 25 | — | 34.4% | ||
| Q1 25 | — | 37.6% | ||
| Q4 24 | — | 33.9% | ||
| Q3 24 | — | 37.2% | ||
| Q2 24 | 99.6% | 37.0% | ||
| Q1 24 | 100.0% | 33.1% |
| Q4 25 | 9.7% | -116.0% | ||
| Q3 25 | 0.8% | 7.0% | ||
| Q2 25 | 13.5% | 4.3% | ||
| Q1 25 | 21.4% | 4.5% | ||
| Q4 24 | 12.7% | 10.0% | ||
| Q3 24 | 23.8% | 7.4% | ||
| Q2 24 | 23.0% | -2.5% | ||
| Q1 24 | 19.4% | -5.1% |
| Q4 25 | 1.9% | -127.8% | ||
| Q3 25 | -0.4% | 0.7% | ||
| Q2 25 | 3.3% | -0.8% | ||
| Q1 25 | 10.9% | -0.6% | ||
| Q4 24 | 7.5% | -3.9% | ||
| Q3 24 | 18.5% | -1.9% | ||
| Q2 24 | 15.9% | -10.2% | ||
| Q1 24 | 11.3% | 0.2% |
| Q4 25 | $0.08 | $-10.23 | ||
| Q3 25 | $-0.02 | $0.05 | ||
| Q2 25 | $0.16 | $-0.06 | ||
| Q1 25 | $0.50 | $-0.05 | ||
| Q4 24 | $0.35 | $-0.32 | ||
| Q3 24 | $0.93 | $-0.15 | ||
| Q2 24 | $0.83 | $-0.79 | ||
| Q1 24 | $0.59 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $377.2M | — |
| Total DebtLower is stronger | $1.4B | — |
| Stockholders' EquityBook value | $5.1B | $2.9B |
| Total Assets | $9.8B | $8.5B |
| Debt / EquityLower = less leverage | 0.27× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $377.2M | — | ||
| Q3 25 | $426.0M | $432.1M | ||
| Q2 25 | $379.6M | $454.2M | ||
| Q1 25 | $392.9M | $409.9M | ||
| Q4 24 | $423.6M | $558.8M | ||
| Q3 24 | $271.2M | $1.5B | ||
| Q2 24 | $333.6M | $542.8M | ||
| Q1 24 | $323.4M | $658.5M |
| Q4 25 | $1.4B | — | ||
| Q3 25 | $1.4B | — | ||
| Q2 25 | $1.5B | — | ||
| Q1 25 | $1.5B | — | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | $1.3B | — | ||
| Q2 24 | $1.3B | — | ||
| Q1 24 | $1.3B | — |
| Q4 25 | $5.1B | $2.9B | ||
| Q3 25 | $5.1B | $4.4B | ||
| Q2 25 | $5.2B | $4.5B | ||
| Q1 25 | $5.1B | $4.4B | ||
| Q4 24 | $5.2B | $4.3B | ||
| Q3 24 | $5.2B | $4.6B | ||
| Q2 24 | $5.3B | $4.5B | ||
| Q1 24 | $5.3B | $4.7B |
| Q4 25 | $9.8B | $8.5B | ||
| Q3 25 | $9.7B | $10.1B | ||
| Q2 25 | $9.8B | $10.1B | ||
| Q1 25 | $9.8B | $9.8B | ||
| Q4 24 | $9.7B | $9.6B | ||
| Q3 24 | $9.7B | $11.2B | ||
| Q2 24 | $9.9B | $10.4B | ||
| Q1 24 | $9.7B | $10.6B |
| Q4 25 | 0.27× | — | ||
| Q3 25 | 0.28× | — | ||
| Q2 25 | 0.28× | — | ||
| Q1 25 | 0.29× | — | ||
| Q4 24 | 0.25× | — | ||
| Q3 24 | 0.24× | — | ||
| Q2 24 | 0.24× | — | ||
| Q1 24 | 0.25× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $249.6M | $175.4M |
| Free Cash FlowOCF − Capex | — | $148.6M |
| FCF MarginFCF / Revenue | — | 13.4% |
| Capex IntensityCapex / Revenue | — | 2.4% |
| Cash ConversionOCF / Net Profit | 20.92× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $145.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $249.6M | $175.4M | ||
| Q3 25 | $339.4M | $51.7M | ||
| Q2 25 | $358.1M | $75.9M | ||
| Q1 25 | $300.7M | $-64.5M | ||
| Q4 24 | $433.6M | $312.6M | ||
| Q3 24 | $429.0M | $42.2M | ||
| Q2 24 | $467.7M | $9.5M | ||
| Q1 24 | $398.8M | $-1.4M |
| Q4 25 | — | $148.6M | ||
| Q3 25 | — | $29.8M | ||
| Q2 25 | — | $56.7M | ||
| Q1 25 | — | $-90.0M | ||
| Q4 24 | — | $274.9M | ||
| Q3 24 | — | $15.1M | ||
| Q2 24 | — | $-18.9M | ||
| Q1 24 | — | $-26.5M |
| Q4 25 | — | 13.4% | ||
| Q3 25 | — | 2.9% | ||
| Q2 25 | — | 5.4% | ||
| Q1 25 | — | -8.6% | ||
| Q4 24 | — | 24.2% | ||
| Q3 24 | — | 1.4% | ||
| Q2 24 | — | -1.8% | ||
| Q1 24 | — | -2.4% |
| Q4 25 | — | 2.4% | ||
| Q3 25 | — | 2.1% | ||
| Q2 25 | — | 1.8% | ||
| Q1 25 | — | 2.4% | ||
| Q4 24 | — | 3.3% | ||
| Q3 24 | — | 2.5% | ||
| Q2 24 | — | 2.7% | ||
| Q1 24 | — | 2.3% |
| Q4 25 | 20.92× | — | ||
| Q3 25 | — | 6.89× | ||
| Q2 25 | 16.06× | — | ||
| Q1 25 | 4.12× | — | ||
| Q4 24 | 8.61× | — | ||
| Q3 24 | 3.08× | — | ||
| Q2 24 | 3.66× | — | ||
| Q1 24 | 4.43× | -0.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MUR
Segment breakdown not available.
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
